This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Inovio Pharmaceuticals Inc (INO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 40.54M 33.72M 5.65M 17.35M
Receivables 2.80M 3.30M 866.67K 506.32K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 98.95M 58.68M 15.97M 31.91M
Property, Plant & Equipment, Gross 7.12M 4.80M 2.48M 2.24M
Accumulated Depreciation & Depletion 2.54M 1.92M 2.12M 1.94M
Property, Plant & Equipment, Net 4.58M 2.89M 363.02K 295.78K
Intangibles 4.78M 5.72M 7.49M 9.31M
Other Non-Current Assets 13.37M 10.88M 11.21M 9.48M
Total Non-Current Assets 32.84M 29.60M 29.17M 29.20M
Liabilities & Shareholder Equity
Total Assets 131.79M 88.29M 45.14M 61.11M
Accounts Payable 6.41M 5.97M 1.04M 1.16M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 2.02M 19.54M 2.86M 5.18M
Total Current Liabilities 14.02M 28.97M 8.38M 11.04M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 504.05K 195.78K 164.39K 78.86K
Other Non-Current Liabilities 5.72M 6.22M 1.74M 2.12M
Minority Interest -18.42K -55.08K -44.02K -51.15K
Total Non-Current Liabilities 6.53M 6.87M 2.41M 2.75M
Total Liabilities 20.56M 35.83M 10.78M 13.79M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 111.23M 52.46M 34.35M 47.31M
Common Par 60.74K 210.30K 144.31K 134.97K
Additional Paid In Capital 443.33M 348.11M 263.90M 257.24M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -331.91M -295.79M -229.76M -210.09M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -251.39K -76.36K 73.36K 35.39K
Total Capitalization 111.23M 52.46M 34.35M 47.31M
Total Equity 111.23M 52.46M 34.35M 47.31M
Total Liabilities & Stock Equity 131.79M 88.29M 45.14M 61.11M
Total Common Shares Outstanding 60.74M 52.58M 36.08M 33.74M
Preferred Shares 23.00 26.00 26.00 26.00
Treasury Shares 0.00 0.00 266.00 0.00
Basic Weighted Shares Outstanding 59.13M 46.09M 34.13M 31.56M
Diluted Weighted Shares Outstanding 59.41M 46.09M 34.13M 31.56M
Number of Employees 106 71 53 53
Number of Part-Time Employees 0 0 0 0
INO News

INO Inovio Pharmaceuticals Inc

Analysts Ratings for INO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET INO ANALYST REPORT

Brokerage Partners

INO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs